This predoctoral training program is dedicated to the training of outstanding scientists in the pharmacological sciences. The program consists of formal coursework, seminar courses focusing on scientific communication skills, short-term research training rotations in 3 laboratories, and original doctoral research. Basic courses in cell biology or neurobiology, molecular biology, biostatistics and advanced pharmacology are required. Elective specialized courses are also required. Departmental seminars and seminar courses acquaint the student with current research in pharmacological sciences and teach them how to present a research seminar with confidence. After finishing their research rotations and qualifying examinations, the students identify a research mentor, propose a research topic, choose an advisory committee, and engage in advanced research. The anticipated duration of training is 5 years. ? ? A great diversity of research areas is available to trainees. The research focus of the 37 core faculty, 22 participating faculty, 84 postdoctoral scientists and 42 graduate students can be grouped into 4 major areas: Cell Surface Receptors, G Proteins, Protein Kinases and Signal Transduction Mechanisms; Neuropharmacology; Nucleic Acids, Cancer & Antimicrobial Pharmacology; and Experimental Therapeutics. Cell and molecular approaches are particularly strong, but systems-level research such as behavioral pharmacology and analysis of knock-in and knock-out mice is also available. Excellent physical facilities are available for all research areas. ? ? The student who completes this predoctoral training program has acquired basic knowledge of pharmacology and related fields, in-depth knowledge in the dissertation research area, the ability to evaluate scientific literature, mastery of a variety of laboratory procedures, skill in planning and executing an important research project in the pharmacological sciences, and the ability to communicate results, analysis, and interpretation. This provides a sound basis for scientific careers in academia, government or industry. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007040-32
Application #
7085337
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1975-07-01
Project End
2010-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
32
Fiscal Year
2006
Total Cost
$230,544
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pharmacology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Yu, Waylin; Hwa, Lara S; Makhijani, Viren H et al. (2018) Chronic inflammatory pain drives alcohol drinking in a sex-dependent manner for C57BL/6J mice. Alcohol :
McCorvy, John D; Wacker, Daniel; Wang, Sheng et al. (2018) Structural determinants of 5-HT2B receptor activation and biased agonism. Nat Struct Mol Biol 25:787-796
Liu, Shijie; Kim, Tae-Hyung; Franklin, Derek A et al. (2017) Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure. Cell Rep 18:1005-1018
Lansu, Katherine; Karpiak, Joel; Liu, Jing et al. (2017) In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat Chem Biol 13:529-536
Di, Jiehui; Tang, Juanjuan; Qian, Heya et al. (2017) p53 upregulates PLC?-IP3-Ca2+ pathway and inhibits autophagy through its target gene Rap2B. Oncotarget 8:64657-64669
Wang, Xianxi; Arceci, Anthony; Bird, Kelly et al. (2017) VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1. Mol Cell Biol 37:
Arend, Kyle C; Lenarcic, Erik M; Vincent, Heather A et al. (2017) Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals. Mol Cell Proteomics 16:S263-S276
Okumu, Denis O; East, Michael P; Levine, Merlin et al. (2017) BIRC6 mediates imatinib resistance independently of Mcl-1. PLoS One 12:e0177871
Miller, Samantha M; Goulet, Daniel R; Johnson, Gary L (2017) Targeting the Breast Cancer Kinome. J Cell Physiol 232:53-60
Cann, Marissa L; McDonald, Ian M; East, Michael P et al. (2017) Measuring Kinase Activity-A Global Challenge. J Cell Biochem 118:3595-3606

Showing the most recent 10 out of 95 publications